Filters
Hikma provides update on generic Advair Diskus® launch
Press Release, Inside Information
Hikma’s commitment to environmental performance recognised with “A-” rating in 2020 CDP Global Climate Change Report
Press Release, Responsibility
Hikma launches generic Advair Diskus® following FDA approval
Press Release, Product
Hikma launches Ropivacaine HCl Injection, USP for anaesthesia and acute pain management
Press Release, Product
Hikma Pharmaceuticals and Sesen Bio announce exclusive partnership to commercialise Vicineum™ in MENA
Press Release, Corporate
Hikma launches Icosapent Ethyl Capsules
Press Release, Product
Hikma continues strong 2020 performance and updates full year guidance
Press Release, Corporate
Hikma launches Rufinamide Oral Suspension, 40 mg/mL
Press Release, Product
Hikma assigned investment grade status from Fitch Ratings
Press Release, Corporate
Hikma and Arecor expand collaboration with new agreement to develop and commercialise ready-to-administer medicine
Press Release, Product
Hikma provides update on status of ANDA for generic Advair Diskus®
Press Release, Corporate
Hikma launches Azacitidine for Injection
Press Release, Product
Hikma Ventures Participates in CAD4.0 million Series A Financing Round for SeamlessMD to Expand Digital Patient Engageme...
Press Release, Corporate
Hikma improves its performance in FTSE4Good Index
Press Release, Corporate
Hikma delivers strong first half performance and raises full year guidance
Press Release, Corporate